195 related articles for article (PubMed ID: 24207130)
1. Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature.
Yahata M; Nakaya I; Sakuma T; Sato H; Aoki S; Soma J
BMC Res Notes; 2013 Nov; 6():450. PubMed ID: 24207130
[TBL] [Abstract][Full Text] [Related]
2. [A case of thrombotic microangiopathy with glomerular subendothelial IgA deposition due to bevacizumab].
Tomita M; Ochiai M; Shu S; Yamauchi Y; Shihara H; Ogata A; Fujisawa N; Yanai Y; Kamata T; Iehara N
Nihon Jinzo Gakkai Shi; 2014; 56(5):612-7. PubMed ID: 25130034
[TBL] [Abstract][Full Text] [Related]
3. Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma.
Roncone D; Satoskar A; Nadasdy T; Monk JP; Rovin BH
Nat Clin Pract Nephrol; 2007 May; 3(5):287-93. PubMed ID: 17457362
[TBL] [Abstract][Full Text] [Related]
4. Bevacizumab-induced immunoglobulin A vasculitis with nephritis: A case report.
Endo Y; Negishi K; Hirayama K; Suzuki H; Shimizu A
Medicine (Baltimore); 2019 Nov; 98(45):e17870. PubMed ID: 31702653
[TBL] [Abstract][Full Text] [Related]
5. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal Antivascular Endothelial Growth Factor Therapy May Induce Proteinuria and Antibody Mediated Injury in Renal Allografts.
Cheungpasitporn W; Chebib FT; Cornell LD; Brodin ML; Nasr SH; Schinstock CA; Stegall MD; Amer H
Transplantation; 2015 Nov; 99(11):2382-6. PubMed ID: 25905984
[TBL] [Abstract][Full Text] [Related]
7. Correlation of paramesangial deposits and glomerular sclerosis and/or hyalinosis in patients with IgA nephropathy.
Tomino Y; Sakai H; Basolo B; Aarons I; Clarkson AR
Tokai J Exp Clin Med; 1986 Oct; 11(4):235-9. PubMed ID: 2441490
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer.
Morimoto M; Arai T; Matsuura M; Ono Y
CEN Case Rep; 2021 Feb; 10(1):6-11. PubMed ID: 32642991
[TBL] [Abstract][Full Text] [Related]
9. Predominant but silent C1q deposits in mesangium on transplanted kidneys - long-term observational study.
Kanai T; Akioka Y; Miura K; Hisano M; Koike J; Yamaguchi Y; Hattori M
BMC Nephrol; 2018 Apr; 19(1):82. PubMed ID: 29625558
[TBL] [Abstract][Full Text] [Related]
10. Glomerular electron-dense deposits in childhood IgA nephropathy.
Yoshikawa N; Ito H; Nakahara C; Yoshiara S; Yoshiya K; Matsuo T; Hasegawa O; Hazikano H; Okada S
Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):33-43. PubMed ID: 3158115
[TBL] [Abstract][Full Text] [Related]
11. [A case of non-IgA mesangioproliferative glomerulonephritis with huge paramesangial hemispherical deposits].
Sugimoto H; Makino H; Wada J; Shikata K; Ikeda S; Ota Z
Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1091-5. PubMed ID: 8230820
[TBL] [Abstract][Full Text] [Related]
12. Pathologic Correlation with Renal Dysfunction after Intravitreal Injections of Vascular Endothelial Growth Factor Antagonists.
Zhang PL; Raza S; Li W; Kanaan HD
Ann Clin Lab Sci; 2021 Nov; 51(6):875-882. PubMed ID: 34921042
[TBL] [Abstract][Full Text] [Related]
13. Henoch-Schönlein purpura in a patient with diabetic nephropathy.
Orfila C; Lepert JC; Modesto A; Pipy B; Suc JM
Am J Kidney Dis; 1994 Sep; 24(3):509-14. PubMed ID: 8079978
[TBL] [Abstract][Full Text] [Related]
14. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
Tsunehisa N; Takemura T; Inui T; Kamiya H
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
[TBL] [Abstract][Full Text] [Related]
15. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
[TBL] [Abstract][Full Text] [Related]
16. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.
Yamada R; Okawa T; Matsuo K; Suzuki M; Mori N; Mori K
BMC Nephrol; 2019 Jan; 20(1):14. PubMed ID: 30634936
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous remission of nephrotic syndrome in a patient with IgA nephropathy.
Hogg RJ; Savino DA
Pediatr Nephrol; 1990 Jan; 4(1):36-8. PubMed ID: 2206879
[TBL] [Abstract][Full Text] [Related]
18. [Bevacizumab and arterial hypertension or proteinuria: management].
Senellart H; Bennouna J
Rev Mal Respir; 2008 Jun; 25(6):767-72. PubMed ID: 18772832
[TBL] [Abstract][Full Text] [Related]
19. Nephrotic-range proteinuria in a patient with a renal allograft treated with sorafenib for metastatic renal-cell carcinoma.
Jonkers IJAM; van Buren M
Clin Exp Nephrol; 2009 Aug; 13(4):397-401. PubMed ID: 19381758
[TBL] [Abstract][Full Text] [Related]
20. Repeat renal biopsy in children with IgA nephropathy.
Yoshikawa N; Iijima K; Matsuyama S; Suzuki J; Kameda A; Okada S; Nakamura H
Clin Nephrol; 1990 Apr; 33(4):160-7. PubMed ID: 2190720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
